Advances and Updates on pathological diagnosis of lymphoma

Bin Meng, Kai Fu

Research output: Contribution to journalArticle

Abstract

The 2008 World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues (4th edition) has greatly advanced the diagnosis, treatment, academic exchange, and research of lymphoma worldwide. A new revised edition will be published soon, in which the diagnosis and management of lesions at the very early stages of lymphomagenesis, the diagnostic criteria for several entities, and the genetic/molecular landscape of numerous lymphoid neoplasms and their clinical correlates have been clarified, refined, detailed, and expanded. Furthermore, several new concepts have been suggested in the upcoming revised edition, although the framework of classification remains the same. These updates will lead to development of more targeted therapeutic strategies and increase our confidence in the era of precision medicine. This manuscript will review the major advances and updates that are helpful for our understanding and improvement in tumor diagnosis.

Original languageEnglish (US)
Pages (from-to)613-619
Number of pages7
JournalChinese Journal of Clinical Oncology
Volume43
Issue number14
DOIs
StatePublished - Jan 1 2016

Fingerprint

Lymphoma
Neoplasms
Precision Medicine
Lymphoid Tissue
Molecular Biology
Therapeutics
Research

Keywords

  • Classification
  • Lymphoma
  • Pathological diagnosis
  • WHO

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Advances and Updates on pathological diagnosis of lymphoma. / Meng, Bin; Fu, Kai.

In: Chinese Journal of Clinical Oncology, Vol. 43, No. 14, 01.01.2016, p. 613-619.

Research output: Contribution to journalArticle

@article{ba983885710a402080d1ff792397b4b6,
title = "Advances and Updates on pathological diagnosis of lymphoma",
abstract = "The 2008 World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues (4th edition) has greatly advanced the diagnosis, treatment, academic exchange, and research of lymphoma worldwide. A new revised edition will be published soon, in which the diagnosis and management of lesions at the very early stages of lymphomagenesis, the diagnostic criteria for several entities, and the genetic/molecular landscape of numerous lymphoid neoplasms and their clinical correlates have been clarified, refined, detailed, and expanded. Furthermore, several new concepts have been suggested in the upcoming revised edition, although the framework of classification remains the same. These updates will lead to development of more targeted therapeutic strategies and increase our confidence in the era of precision medicine. This manuscript will review the major advances and updates that are helpful for our understanding and improvement in tumor diagnosis.",
keywords = "Classification, Lymphoma, Pathological diagnosis, WHO",
author = "Bin Meng and Kai Fu",
year = "2016",
month = "1",
day = "1",
doi = "10.3969/j.issn.1000-8179.2016.14.602",
language = "English (US)",
volume = "43",
pages = "613--619",
journal = "Chinese Journal of Clinical Oncology",
issn = "1672-7118",
publisher = "China Anti-Cancer Association",
number = "14",

}

TY - JOUR

T1 - Advances and Updates on pathological diagnosis of lymphoma

AU - Meng, Bin

AU - Fu, Kai

PY - 2016/1/1

Y1 - 2016/1/1

N2 - The 2008 World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues (4th edition) has greatly advanced the diagnosis, treatment, academic exchange, and research of lymphoma worldwide. A new revised edition will be published soon, in which the diagnosis and management of lesions at the very early stages of lymphomagenesis, the diagnostic criteria for several entities, and the genetic/molecular landscape of numerous lymphoid neoplasms and their clinical correlates have been clarified, refined, detailed, and expanded. Furthermore, several new concepts have been suggested in the upcoming revised edition, although the framework of classification remains the same. These updates will lead to development of more targeted therapeutic strategies and increase our confidence in the era of precision medicine. This manuscript will review the major advances and updates that are helpful for our understanding and improvement in tumor diagnosis.

AB - The 2008 World Health Organization Classification of Tumors of Hematopoietic and Lymphoid Tissues (4th edition) has greatly advanced the diagnosis, treatment, academic exchange, and research of lymphoma worldwide. A new revised edition will be published soon, in which the diagnosis and management of lesions at the very early stages of lymphomagenesis, the diagnostic criteria for several entities, and the genetic/molecular landscape of numerous lymphoid neoplasms and their clinical correlates have been clarified, refined, detailed, and expanded. Furthermore, several new concepts have been suggested in the upcoming revised edition, although the framework of classification remains the same. These updates will lead to development of more targeted therapeutic strategies and increase our confidence in the era of precision medicine. This manuscript will review the major advances and updates that are helpful for our understanding and improvement in tumor diagnosis.

KW - Classification

KW - Lymphoma

KW - Pathological diagnosis

KW - WHO

UR - http://www.scopus.com/inward/record.url?scp=85018904614&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018904614&partnerID=8YFLogxK

U2 - 10.3969/j.issn.1000-8179.2016.14.602

DO - 10.3969/j.issn.1000-8179.2016.14.602

M3 - Article

AN - SCOPUS:85018904614

VL - 43

SP - 613

EP - 619

JO - Chinese Journal of Clinical Oncology

JF - Chinese Journal of Clinical Oncology

SN - 1672-7118

IS - 14

ER -